Cobalis Corp. (fka CLSC)

[MPTIU82]

Would expect no share re-issuance to be required if Cobalis executes sales of PreHistin successfully and soon, is discharged from BK 11, and is not forced into BK 7 by negotiating an acceptable payment plan to satisfy secured creditor, namely YA Global.

Would expect payment plan to be from new funding and expected revenues from sale of PreHistin and other potential products to be sold by Cobalis once Prehistin launch complete. Cobalis shares would just continue to trade OTC PK..

If they can satsfy the above near term...that is.